M MN1 Pill - pink round, 13mm
Pill with imprint M MN1 is Pink, Round and has been identified as Metformin Hydrochloride Extended Release 1000 mg. It is supplied by Mylan Pharmaceuticals Inc.
Metformin is used in the treatment of Diabetes, Type 2 and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M MN1
Metformin Hydrochloride Extended Release
- Imprint
- M MN1
- Strength
- 1000 mg
- Color
- Pink
- Size
- 13.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Non-sulfonylureas
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6001
- Inactive Ingredients
-
ammonia,
ferrosoferric oxide,
cellulose acetate,
lactose monohydrate,
magnesium stearate,
propylene glycol,
ferric oxide red,
shellac,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
triacetin,
triethyl citrate,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "M MN1"
More about metformin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (645)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: non-sulfonylureas
- Breastfeeding
Patient resources
- Metformin drug information
- Metformin Extended-Release Suspension
- Metformin Extended-Release Tablets
- Metformin Tablets
- Metformin Oral Solution
Other brands
Glucophage, Glumetza, Fortamet, Glucophage XR, ... +2 more
Professional resources
- MetFORMIN monograph
- Metformin (FDA)
- Metformin Aerosol (FDA)
- Metformin Extended Release Tablet (FDA)
- Metformin Extended Release Tablets (FDA)
- Metformin Oral Solution (FDA)
Other brands
Glucophage, Glumetza, Fortamet, Glucophage XR, Riomet
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
